Crossmark

The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy

Crossref DOI link: https://doi.org/10.1038/bjc.2017.57

Published Online: 2017-03-28

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Simmons, Lucy A M

Kanthabalan, Abi

Arya, Manit

Briggs, Tim

Barratt, Dean

Charman, Susan C

Freeman, Alex

Gelister, James

Hawkes, David

Hu, Yipeng

Jameson, Charles

McCartan, Neil

Moore, Caroline M

Punwani, Shonit

Ramachandran, Navin

van der Meulen, Jan

Emberton, Mark

Ahmed, Hashim U
License Information

Text and Data Mining valid from 2017-03-28
More Information

Article History

Received: 23 July 2016

Revised: 22 January 2017

Accepted: 6 February 2017

First Online: 28 March 2017

Competing interests

: HUA receives funding from Sonacare Medical, Sophiris and Trod Medical for other trials. Travel allowance was previously provided from Sonacare Inc. ME has stock interest in Nuada Medical Ltd. He is also a consultant to Steba Biotech and GSK. He receives travel funding from Sanofi Aventis, Astellas, GSK and Sonacare. He previously received trial funding or resources from GSK, Steba Biotech and Angiodynamics and currently receives funding for trials from Sonacare Inc., Sophiris Inc. and Trod Medical. AF has stock interest in Nuada Medical Ltd. DH is a founder shareholder in IXICO plc. DB and YH have a patent in image fusion, called SmartTarget. CMM receives funding from ProfBiotics and GSK. All the others authors declare no conflict of interest.